Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2014

Equity [Abstract]

Share-Based Activity

Other information pertaining to share-based activity for the years ended December 31, 2014, 2013 and 2012 was as follows (in thousands):

	2014		2013		2012
Share-based compensation expense	$	10,104	$	8,321	$	6,692
Fair value of shares vested	15,126		11,742		6,425
Cash received from option exercises	2,630		33,349		18,214
Tax benefit from option exercises	3,177		7,247		1,784

Schedule Of Changes In Non-Vested Restricted Shares

A summary of the status of and changes for non-vested restricted shares for the three years ended December 31, 2014, is as follows:

			Weighted
	Number		Average
	of Shares		Grant Price
Non-vested shares at January 1, 2012	732,412		$	21.91
Shares granted	281,429		26.78
Shares vested	(183,019	)	25.98
Shares forfeited	(2,136	)	26.26
Non-vested shares at December 31, 2012	828,686		$	22.50
Shares granted	291,863		31.66
Shares vested	(360,337	)	21.55
Shares forfeited	(16,343	)	23.11
Non-vested shares at December 31, 2013	743,869		$	26.54
Shares granted	272,780		43.12
Shares vested	(336,160	)	25.69
Shares forfeited	(12,380	)	38.94
Non-vested shares at December 31, 2014	668,109		$	33.51

Schedule Of Stock Option Activity

A summary of stock option activity for the three years ended December 31, 2014 is summarized as follows:

					Weighted
			Weighted		Average
			Average		Remaining
	Number		Exercise		Contractual
	of Shares		Price		Term (in years)
Outstanding at January 1, 2012	2,510,054		$	23.09	3.4
Options exercised with total intrinsic value of $6.3 million	(841,599	)	21.64
Options terminated	(5,625	)	21.85
Outstanding at December 31, 2012	1,662,830		$	23.82	2.9
Options exercised with total intrinsic value of $33.3 million	(1,392,366	)	23.95
Outstanding at December 31, 2013	270,464		$	23.16	2.5
Options exercised with total intrinsic value of $2.6 million	(111,743	)	23.53
Outstanding, Vested and Exercisable at December 31, 2014 with an aggregate intrinsic value of $3.6 million	158,721		$	22.89	1.7

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

The following is a reconciliation of the numerator and denominators of basic and diluted earnings per share (in thousands, except per share amounts):

	Earnings		Shares	Per Share
	(Numerator)		(Denominator)	Amount
For the year ended December 31, 2014:
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	50,777	39,311	$	1.29
Effect of dilutive securities options and non-vested shares	—		314
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	50,777	39,625	$	1.28
For the year ended December 31, 2013:
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	71,009	31,338	$	2.27
Effect of dilutive securities options and non-vested shares	—		616
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	71,009	31,954	$	2.22
For the year ended December 31, 2012:
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	60,037	30,773	$	1.95
Effect of dilutive securities options and non-vested shares	—		835
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	60,037	31,608	$	1.90